116 related articles for article (PubMed ID: 19939506)
1. [Retrospective study of etanercept use in elderly people with psoriasis].
Ruiz-Villaverde R; Sanchez-Cano D; Abalos-Medina GM
Rev Esp Geriatr Gerontol; 2010; 45(1):56-7. PubMed ID: 19939506
[No Abstract] [Full Text] [Related]
2. Rapid response of nail psoriasis to etanercept.
Rallis E; Stavropoulou E; Rigopoulos D; Verros C
J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
[No Abstract] [Full Text] [Related]
3. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
Fabrizi G; Guerriero C; Pagliarello C
Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
[No Abstract] [Full Text] [Related]
4. Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept).
Kasche A; Pfab F; Hein R; Athanasiadis GI; Ollert M; Ring J; Eberlein-König B
J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):255-7. PubMed ID: 17243968
[No Abstract] [Full Text] [Related]
5. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
De Simone C; Carbone A; Caldarola G
Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
7. Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis.
Huo R; Romanelli P
Am J Clin Dermatol; 2010; 11 Suppl 1():39-40. PubMed ID: 20586506
[TBL] [Abstract][Full Text] [Related]
8. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
Prestinari F; Ferguglia G; Laria G
Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
[TBL] [Abstract][Full Text] [Related]
9. Managing pediatric patients with psoriasis.
Bard S; Torchia D; Schachner LA
Am J Clin Dermatol; 2010; 11 Suppl 1():15-7. PubMed ID: 20586500
[TBL] [Abstract][Full Text] [Related]
10. Commentary on the European S3-guidelines on the systemic treatment of psoriasis.
Giannetti A
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):368; author reply 368-9. PubMed ID: 20070453
[No Abstract] [Full Text] [Related]
11. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.
Lee ES; Heller MM; Kamangar F; Park KK; Koo JY
J Drugs Dermatol; 2012 Mar; 11(3):413-4. PubMed ID: 22395596
[TBL] [Abstract][Full Text] [Related]
12. A patient with psoriasis and vitiligo treated with etanercept.
Campanati A; Giuliodori K; Ganzetti G; Liberati G; Offidani AM
Am J Clin Dermatol; 2010; 11 Suppl 1():46-8. PubMed ID: 20586509
[TBL] [Abstract][Full Text] [Related]
13. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
14. Marked improvement in nail psoriasis during treatment with etanercept.
Gómez Vázquez M; Navarra Amayuelas R
Dermatol Ther; 2011; 24(5):498-500. PubMed ID: 22353156
[TBL] [Abstract][Full Text] [Related]
15. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
16. Pilot study using teledermatology to manage high-need patients with psoriasis.
Frühauf J; Schwantzer G; Ambros-Rudolph CM; Weger W; Ahlgrimm-Siess V; Salmhofer W; Hofmann-Wellenhof R
Arch Dermatol; 2010 Feb; 146(2):200-1. PubMed ID: 20157037
[No Abstract] [Full Text] [Related]
17. Etanercept: effectiveness and safety data of a retrospective study.
Antoniou C; Vergou T; Dessinioti C; Stratigos AJ; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1113-5. PubMed ID: 20673305
[No Abstract] [Full Text] [Related]
18. A case of severe psoriasis with an apparent incomplete response to anti-tumour necrosis factor alpha treatment.
Agnusdei CP; Mastronardi C
Am J Clin Dermatol; 2010; 11 Suppl 1():41-3. PubMed ID: 20586507
[TBL] [Abstract][Full Text] [Related]
19. Etanercept and psoriasis, from clinical studies to real life.
Jacob SE; Sergay A; Kerdel FA
Int J Dermatol; 2005 Aug; 44(8):688-91. PubMed ID: 16101875
[TBL] [Abstract][Full Text] [Related]
20. Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage.
Gambichler T; Tigges C; Dith A; Skrygan M; Scola N; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jan; 164(1):110-5. PubMed ID: 20973771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
